Positive rejections for latest NICE IPPs
This article was originally published in Clinica
Executive Summary
The two innovative technologies on which the UK's National Institute for Health and Clinical Excellence (NICE) issued guidance this week were deemed not to have the long-term efficacy data required by the agency. But the interventional procedure programme (IPP) appraisals of "implantation miniature lens systems for advanced age-related macular degeneration" and "total wrist replacement" were notably positive in highlighting the evolving nature of these technologies and their prospective review. The next round of IPP guidelines, due out on September 24, will cover: autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy; and balloon catheter dilation of paranasal sinus ostia for chronic sinusitis.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.